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Figure 1. Schematic diagram of the neural circuitry of relevance to the interaction of GABAergic, 
serotonergic, noradrenergic, dopaminergic and glutamatergic neurotransmission and BDNF/TrkB 
modulatory presynaptic connections on glutamatergic pyramidal cells in the prefrontal cortex and 
hippocampus. VTA = ventral tegmental area. GABAergic interneurons and the apical dentrites of 
glutamatergic pyramidal neurons of prefrontal cortex are modulated by the noradrenergic projections 
from the locus coereleus (LC) and by the serotonergic projections from the raphe nuclei (RN). The 
activation of glutamatergic pyramidal neurons of the prefrontal cortex modulates glutamatergic 
neuronal activity in the hippocampus and has glutamatergic feedback connections both directly to the 
LC and the RN. There are reciprocal modulatory projections between the LC and RN. Stimulation of 
both synaptic NMDA receptors and AMPA receptors can activate the phosphorylation of CREB and 
enhance the expression of BDNF and TrkB. Increased expression and release of BDNF and activation 
of TrkB promote the function, sprouting and regrowth of 5-HT and NA containing neurons (Altar 1999). 
Activation of glutamate receptors stimulates the Ca2+ -calmodulin- nitric oxide (NO) cascade and leads 
to the synthesis and release of NO. NO may be able to stimulate the release of DA and NA, 
depending on NMDA receptor stimulation. The mesolimbic DA system originates from the VTA and 
projects to the limbic striatum, including the nucleus accumbens (not shown), to the amygdaloid body 
(not shown) and to other limbic areas, such as the prefrontal cortex. DA neurons in the VTA receive 
direct excitative glutamatergic innervation (via both ionotropic and metabotropic receptors) from the 
prefrontal cortex. (Modified from Paul and Skolnick 2003)  
 
Hippocampus 
 
                                                                            
Prefrontal cortex 
 
 GLU BDNF/ 
TrkB
GABA GABA 
Locus 
coeruleus 
(LC) 
Raphe 
nuclei 
(RN) 
Hypothalamus 
BDNF/
TrkB
VTA 
DA 
28 
 
 
2.2.1.  Monoamine hypothesis of depression 
 
According to the monoamine hypothesis of depression, depression is due to the 
reduced availability of monoamine neurotransmitters, dopamine (DA), serotonin (5-
hydroxytryptamine (5-HT) and noradrenaline (NA, called also norepinephrine (NE)).   
Ascending and descending tracts of DA, 5-HT and NA systems project to the limbic 
and prefrontal cortex as well as to the striatum and other cortical areas. The cingulate 
gyrus has extensive projections to the basal, medial, and lateral surfaces of the 
cerebral hemispheres. The monoamine receptors are distributed in the cortical 
regions, the striatum and the limbic system. This network is involved in modulation 
and feedback mechanisms among the brain regions. (Trivedi and Husain 1997) 
 The presynaptic monoaminergic neurons have reuptake pumps called 
transporters that are selective for each monoamine. They are called the DA 
transporter (DAT), serotonin transporter (SERT) and norepinephrine transporter 
(NET). In the normal state there is a balance between monoamine synthesis, release 
and neurotransmission. According to the monoamine hypothesis, in the case of 
depression the monoamine neurotransmitters are depleted, causing neurotransmitter 
deficiency. DA and NA can be eliminated by enzymes in the neuron. The principal 
destructive enzymes are monoamine oxidase (MAO) and catechol-O-methyl 
transferase (COMT). The action of DA and NA can be terminated not only by 
enzymes, but also by DAT and NET.  Serotonin can also be eliminated by the MAO 
enzyme and converted into an inactive metabolite. The SERT is analogous to the 
DAT and NET. The transporter prevents monoamine from acting on the synapse 
without destroying it. It takes monoamine back into the cell from the synaptic cleft 
and off the synaptic receptors, stopping its synaptic actions. Inside the presynaptic 
nerve terminal, monoamine can be stored again for reuse when another nerve 
impulse arrives or it can be metabolized by enzymes. (Stahl 2001) 
 The neurotransmitter receptor hypothesis of depression posits that the depletion 
of neurotransmitter causes compensatory up-regulation of postsynaptic 
neuroreceptors, which may prevent normal neurotransmission by absorbing 
neurotransmitters from the synaptic cleft and thus causing a depletion of monoamine 
neurotransmitter in there. The monoamine hypothesis of gene action in depression 
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Figure 2. SPECT scans of a depressed patient (left) and a healthy control (right). Arrows 
indicate the left basal ganglia region. The striatal DAT density is significantly higher 
in the patient than the healthy control.  The increase in DAT density is shown by 
the brighter colour (white). 
 
 
5.3.  Effect of cluster C personality disorder on striatal dopamine transporter 
densities in major depression (III) 
 
There were no differences in background or in clinical characteristics between the 
study groups (Table 3). Furthermore, we found no differences in radioligand 
presynaptic uptake (transporter density) between depression groups, but a difference 
of over 20% in DAT densities between the depression groups and the control group. 
There was no significant difference (effect size: 0.28 on the right and 0.17 on the left) 
in DAT densities between the major depression patients with cluster C PD and those 
with pure major depression. When DAT densities were compared between patients 
with major depression and healthy controls, the effect size was 1.44 on both sides of 
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basal ganglia. Since the confidence intervals of the pure depression group remained 
within the limits of the confidence intervals of the cluster C PD group, there were 
clearly no differences in DAT densities among patients with major depression 
between the groups with or without cluster C PD.  
 Earlier administration of psychopharmacological medication to some of the 
patients had no effect on the results. In the analysis of variance (dependent variable: 
right and left basal ganglia separately; factor: cluster C PD) and when adjusted for 
age (covariate: age), only age had an effect on DAT density in both sides of basal 
ganglia region (p = 0.04 on the right side and p = 0.015 on the left side). Spearman’s 
correlations were calculated between the severity of depression (HRSD score, BDI 
score) and DAT density in the basal ganglia of the cluster C group (correlation co-
efficient for HRSD vs DAT, -0.29 on the right side and -0.27 on the left side; and BDI 
score vs DAT, 0.26 on the right side and 0.24 on the left side, respectively) and pure 
depression group (0.19 on the right side and 0.01 on the left side; and -0.27 on the 
right side and -0.16 on the left side, respectively). 


75 
 
 
difference between the responders and the non-responders in [123I]β-CIT binding in 
the midbrain region at the six-month follow-up was also statistically significant 
(ANCOVA: F = 6.98; df = 1, 14; p = 0.019). There were no significant differences in 
[123I]β-CIT binding between the responders and the non-responders in other brain 
regions. 
 
 
 
Figure 3. SPECT scan of a recovered patient before (left) and after recovery (right) from 
depression. The arrows indicate the midbrain region. The increase in [123I]β-CIT 
binding is shown as brighter colour (white).  
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6   DISCUSSION 
 
6.1.  Benzodiazepine receptor density in major depression (I) 
 
6.1.1.  Lower benzodiazepine receptor densities in several brain regions 
  
Our results showed that the densities of benzodiazepine receptors within several 
areas of the brain were lower in depressed patients than in the controls. The 
decrease in the benzodiazepine receptor density was most prominent in the left 
temporal lobe. Our results are in accordance with earlier studies implicating GABA-
benzodiazepine receptor density in the pathogenesis of anxiety (Sadzot and Frost 
1990). 
 We also found a significant decrease in the regional uptake of the temporal 
cortex, which is partly in line with the results obtained from previous studies on panic 
disorder patients (Feistel 1993, Kaschka et al. 1995), and on patients with GAD 
(Tiihonen et al. 1997a). We suggest that the benzodiazepine receptor density in the 
left temporal pole of depressed patients resembles that of patients with GAD or panic 
disorder. Our patients also had lower densities of benzodiazepine receptor in the 
right temporal pole, prefrontal cortices and both hemispheres. However, it might be 
possible that our results did not separate the effects of tracer delivery from the 
binding, due to the relatively short interval (90-120 min) used between injection and 
scanning. Therefore, these results are offered as semiquantitative target-to-
cerebellum ratios, and not as ”true” specific bindings. 
 
6.1.2.  Anxiety and altered GABA-benzodiazepine function 
 
Anxiety may also be caused by altered GABA-benzodiazepine function resulting from 
increased endogenous inverse agonism, benzodiazepine receptor spectrum 
changes, decreased endogenous agonism or a combination of these (Busatto et al. 
1997). The same mechanism may be possible in major depression. Furthermore, 
since receptor spectrum changes per se would not change the number of receptors, 





























